Medicover stock

MCOV.B · Nasdaq Stockholm · SEK

Compare Medicover
kr 256.50Change from previous close: −0.97%Absolute change: −kr 2.50

Close · November 20, 2026

Price history

+12.50% over the period

1 year: from kr 228.00 (November 20, 2025) to kr 256.50 (November 20, 2026), +12.50%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 20, 2026kr 256.50
October 30, 2026kr 283.50
September 30, 2026kr 260.00
August 31, 2026kr 242.50
July 31, 2026kr 225.50
June 30, 2026kr 230.00
May 29, 2026kr 209.00
April 30, 2026kr 207.50
March 31, 2026kr 188.20
February 27, 2026kr 217.50
January 30, 2026kr 202.50
December 30, 2025kr 220.50
November 28, 2025kr 235.50
November 20, 2025kr 228.00

At a glance

  • The company

    Provides healthcare and diagnostic services including outpatient/inpatient care, dental care, mental health, orthopedics, hospital care and laboratory diagnostics

  • Latest results

    Quarter to September 30, 2026 · EPS €0.16 (estimate €0.17)

TickerLandia's take on Medicover

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk lowkr 179.40
52-wk highkr 284.50

−9.84% from the 52-week high

Analysts · 7 analysts

Average targetkr 287.61+12.13% vs. price

Buy 5 · Hold 2 · Sell 0 · Buy

TickerLandia Fingerprint: Medicover

Compared with similar companies: very high price and very low financial strength.

Financials and price compared with 19 companies in the medical care facilities industry, worldwide. Momentum and risk compared with 1,160 European stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Medicover is pricier than similar companies

Medicover's P/E (trailing 12 months): 38.3, +72% against the median of a group of 10 similar companies (22.3).

Compared with 10 similar companies

Medicover's metrics compared with similar companies
MetricMedicoverPosition in the groupBand
P/E (trailing 12 months)38.3Middle
Operating margin7.4%Low
ROE15.8%Middle
Debt/equity2.26High
Price/book72.2High

Grey band: the middle half of the group; tick: the median; dot: Medicover. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

€570.8M

Latest quarter · Q3 2026

Net income

€25.7M

Latest quarter · Q3 2026

Quarterly net margin

4.5%

Latest quarter · Q3 2026

Numbers and valuation

Full valuation
Market cap
kr 38.98B
P/E
38.3
EPS
kr 6.70
Volume
36.94K
Daily trading
€1.79M
Dividend yield
0.85%
Last ex-dividend on April 30, 2026

How Medicover is changing

All results
  • Revenue grew 19.0% a year on average over the last 5 years

  • Operating margin rose from 4.5% to 6.6%

  • Shares outstanding up 6.5% in 5 years

Returns

Medicover returns with dividends

kr 1,000 invested in Medicover 5 years ago, on November 22, 2021, would be worth kr 928 today with dividends reinvested: −7.22% in total, −1.49% per year. On price alone it would be kr 891 (−10.94%).

PeriodMedicoverkr 1,000 becomes
1 month−3.57%kr 964
6 months+19.86%kr 1,199
Year to date+16.33%kr 1,163
1 year+13.68%kr 1,137
3 years+81.44%kr 1,814
5 years−7.22%kr 928

From 1 year up with dividends reinvested, before taxes; under a year price only. Calculate your investment

The chart in detail

Medicover: technical analysis

Medicover shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 30.7% below its all-time closing high (kr 370.00, December 30, 2021).

Trend
No clear trend
RSI (14 sessions)
37
Between 30 and 70
vs 200-session average
+12.96%

Support and resistance

Price areas where Medicover has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistancekr 259.25+1.07%2 touches, last on November 6, 2026
  2. Last pricekr 256.50
  3. Supportkr 249.75−2.63%2 touches, last on September 29, 2026
  4. Supportkr 231.50−9.75%2 touches, last on September 11, 2026
  5. Supportkr 223.67−12.80%3 touches, last on February 23, 2026

Volatility and risk

Volatility (60 sessions, annualised)
20.4%
Largest fall in the last year
−22.63%

Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Medicover: seasonality

Average monthly price change over 10 years

+1.9%Jan+1.1%Feb−8.0%Mar+11.1%Apr+3.2%May−0.4%Jun+3.6%Jul−1.2%Aug−0.4%Sep+2.2%Oct+5.4%Nov+4.8%Dec

Over the last 10 years, the strongest month for Medicover has been April: +11.07% on average, positive in 7 years out of 9. The weakest has been March: −7.95% on average, positive in 1 years out of 9. November, the current month, has been positive in 5 years out of 9 (+5.42% on average).

Show chart data
MonthAverageMedianPositive years
January+1.92%−2.32%4 of 9
February+1.13%+4.16%6 of 9
March−7.95%−9.00%1 of 9
April+11.07%+10.32%7 of 9
May+3.22%+0.72%6 of 9
June−0.42%+0.76%5 of 10
July+3.58%+1.83%6 of 10
August−1.20%−1.20%3 of 10
September−0.37%−1.96%4 of 10
October+2.16%+3.24%6 of 10
November+5.42%+9.87%5 of 9
December+4.80%+3.88%5 of 9

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Medicover and its competitors

Dental care, outpatient clinics, mental health care and diagnostic laboratory tests are the services people most often associate with Medicover. The group provides healthcare and diagnostic services in Poland, Sweden and other markets. Its Healthcare Services segment covers outpatient and inpatient care, hospital care, orthopedics, preventive plans, sports and wellness, and benefit cards, while its Diagnostic Services segment covers tests such as microbiology, human genetics, haematology and histopathology. Its clients are corporate customers, individuals and public sector bodies.

Headquarters
Stockholm, Sweden
Employees
49,000
Founded
1995
Chief executive
John Stubbington
Medicover and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
MedicoverMCOV.B$3.82B7.4%38.3+19.86%
Fresenius Medical CareFME$10.72B10.1%12.3−2.36%
Spire Healthcare GroupSPI$1.3B7.6%—+12.90%
TerveystaloTTALO$830.61M8.9%13.0−27.00%
FreseniusFRE$31.8B9.9%18.4+27.91%
Mouwasat Medical Services4002$3.16B25.8%13.5−14.59%

Same industry or related industries, similar size. Compare Medicover with its competitors · Full profile